BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6521088)

  • 1. [Immunosuppressive acidic protein (IAP) levels in sarcoidosis].
    Nakata Y; Kobayashi Y; Kishi T; Ejiri T; Ohnoshi T; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Sep; 22(9):751-6. PubMed ID: 6521088
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum immunosuppressive acidic protein (IAP) in patients with hematological disorders].
    Kumagai T; Asou N; Kumagai E; Toda M; Torigoe T; Kajiwara N; Mori M; Yamaguchi K
    Rinsho Byori; 1986 Dec; 34(12):1413-6. PubMed ID: 2882039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in immunosuppressive acidic protein (IAP) values with aging].
    Kumagai E; Hara Y; Higashi K; Shikai A; Mori Y; Tanaka R; Kumagai T
    Rinsho Byori; 1986 Mar; 34(3):287-90. PubMed ID: 3712789
    [No Abstract]   [Full Text] [Related]  

  • 5. [T-lymphocyte subpopulations in sarcoidosis].
    Gergert VIa; Miuller Sh; Kolodiazhnaia NS
    Probl Tuberk; 1984 Sep; (9):65-9. PubMed ID: 6334302
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
    Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene in respiratory sarcoidosis].
    Ruszel KB; Rzepkowska G
    Wiad Lek; 1981 Jul; 34(14):1151-5. PubMed ID: 7331317
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical study on serum sialic acid and immunosuppressive acidic protein (IAP) as inflammatory parameter in non-malignant pulmonary diseases].
    Reshad K; Suzuki K; Shimada T
    Bull Chest Dis Res Inst Kyoto Univ; 1986 Mar; 19(1-2):56-70. PubMed ID: 3580583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Macrophage function in sarcoidosis. I. Suppressed oxidative metabolism of macrophages in sarcoidosis in correlation with inflammation].
    Müller-Quernheim J; Rubin R; Leimer L; Ferlinz R
    Prax Klin Pneumol; 1983 Oct; 37(10):1130-3. PubMed ID: 6647236
    [No Abstract]   [Full Text] [Related]  

  • 10. [Suppression of macrophage chemotaxis by sera from patients with pulmonary sarcoidosis].
    Okuyama Y; Terai T; Yozawa H; Abe S; Osaki Y; Murao M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Jun; 20(6):663-8. PubMed ID: 7131986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of urinary immunosuppressive acidic protein in cancer patients].
    Hirayama T; Tamura K; Kikuchi S; Shibata Y; Kanno H; Sato Y; Ishida N; Kikuchi K
    Gan No Rinsho; 1983 Sep; 29(11):1323-9. PubMed ID: 6685196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on assay method and dynamics of Fc-receptor activity of pulmonary alveolar macrophages in sarcoidosis].
    Nakano I; Tsuneta Y; Terai T; Yozawa H; Abe S; Ohsaki Y; Murao M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Dec; 19(12):984-91. PubMed ID: 6965216
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and characterization of an immunosuppressive protein in serum of patients with sarcoidosis.
    Göring HD; Lukowsky A; Schubert H; Schwalm I; Leib I
    Dermatol Monatsschr; 1984; 170(2):96-101. PubMed ID: 6724068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive acidic protein (IAP) level in serum and peritoneal washings, and its implication in determining multidisciplinary treatments.
    Takenoshita S; Tsukada K; Nakamura J; Shitara Y; Asao T; Kato R; Kojima T; Nagashima M; Nagamachi Y
    Anticancer Res; 1996; 16(4B):2269-72. PubMed ID: 8694554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphocyte markers in sarcoidosis and tuberculosis].
    Munker M; Munker R; Kiggen E; Cujnik F; Thierfelder S
    Prax Klin Pneumol; 1984 Oct; 38(10):456-9. PubMed ID: 6334290
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible afferent limb immune defect in sarcoid lymphocytes.
    Ogunye O; Young R
    East Afr Med J; 1982 Mar; 59(3):199-205. PubMed ID: 6982809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitation of immunosuppressive acidic protein and carcinoembryonic antigen in sputum from patients with various respiratory diseases].
    Tanno Y; Konishi K; Nishioka K; Takishima T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Jul; 20(7):770-6. PubMed ID: 7143828
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
    Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
    Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis.
    Hällgren R; Håkansson L; Schmekel B; Stålenheim G; Venge P
    Clin Exp Immunol; 1982 Jan; 47(1):169-75. PubMed ID: 7094421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.